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Abstract: Nonlinear spectral imaging microscopy (NSIM) allows 
simultaneous morphological and spectroscopic investigation of intercellular 
events within living animals. In this study we used NSIM for in vivo time-
lapse in-depth spectral imaging and monitoring of protein-bound and free 
reduced nicotinamide adenine dinucleotide (NADH) in mouse keratinocytes 
following total acute ischemia for 3.3 h at ~3 min time intervals. The high 
spectral resolution of NSIM images allows discrimination between the two-
photon excited fluorescence emission of protein-bound and free NAD(P)H 
by applying linear spectral unmixing to the spectral image data. Results 
reveal the difference in the dynamic response between protein-bound and 
free NAD(P)H to ischemia-induced hypoxia/anoxia. Our results dem–
onstrate the capability of nonlinear spectral imaging microscopy in 
unraveling dynamic cellular metabolic events within living animals for long 
periods of time. 
©2011 Optical Society of America 
OCIS codes: (110.4234) Multispectral and hyperspectral imaging; (170.1470) Blood or tissue 
constituent monitoring; (180.2520) Fluorescence microscopy; (190.4180) Multiphoton 
processes. 
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1. Introduction 
The autofluorescence of reduced nicotinamide adenine dinucleotides (NADH) can reveal the 
metabolic state of a cell. For decades now, NADH, the principal electron donor in glycolytic 
and oxidative energy metabolism, has been used as a convenient noninvasive probe of cellular 
metabolic state [1]. Although it exists in an oxidized (NAD
+) and a reduced (NADH) form, 
only NADH is intrinsically fluorescent, whereas its oxidized product (NAD
+) is not. Chance 
et al. took advantage of this phenomenon and demonstrated that microfluorometry of NADH 
provides a means to probe the oxidation-reduction state of cells and tissues [1]. This 
pioneering work opened the door to more studies that utilized probing NADH fluorescence to 
reveal the metabolic activity within the cell. The emergence of nonlinear-excited fluorescence 
microscopy paved the way to a new era of cellular imaging in thick samples as well as living 
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to in vivo conditions [5,6]. 
In recent years, there have been a growing number of reports on studies of NADH that 
were largely focused on time-resolved fluorescence and anisotropy measurements 
demonstrating capability to discriminate protein-bound and free NADH in the intracellular 
environment [7–13]. In principle, discrimination between protein-bound and free NADH is 
also achievable by fluorescence emission spectroscopy. However, high spectral resolution 
measurement is necessary to discriminate the two emission bands due to close proximity of 
their spectral peaks (λboundNADH 445 nm; λfreeNADH 460 nm) and their large spectral overlap 
(ΔλboundNADH ΔλfreeNADH 90 nm). To address this issue, we developed high-resolution spatial 
and spectral nonlinear spectral imaging microscopy (NSIM) [14,15]. This technique combines 
spectral imaging microscopy [16,17] with nonlinear microscopy (multiphoton-excited 
fluorescence and second harmonic generation) to obtain spectrally-resolved optical sections of 
living tissues. Further implementation of linear spectral unmixing showed the potential of 
NSIM in obtaining biochemical information from in-vivo spectral images of mouse [3,4,18] 
and human skin [19]. In this study, we demonstrate the capability of NSIM to discriminate in-
vivo protein-bound and free NADH in mouse keratinocytes following total acute ischemia. 
Moreover, the use of low excitation power levels and the inherent localization of nonlinear 
excitation allowed us to acquire spectral images for up to 3.3 hr with minimal photobleaching. 
2. Materials and method 
2.1. Animal model 
The Committee on Animal Research of the Erasmus University Rotterdam approved the 
experimental protocol. The skin of two female inbred albino hairless mice (SKH1 HR, 
Charles River, Someren, The Netherlands) was used in vivo. The mice were fed on a diet free 
of chlorophyll (Hope Farms BV, Woerden, The Netherlands) for a minimum of 2 weeks 
before starting the experiments to remove the autofluorescence emission from mouse skin 
centered at 675 nm attributed to pheophorbide-a [20]. The mice were placed on a home-made 
temperature-controlled microscope stage. During pre-ischemia imaging, the mice were 
anaesthetized using Ketamine (80mg/kg, Janssen Pharmaceutica, Tilburg, The Netherlands) 
and Rompun (10mg/kg Janssen Pharmaceutica, Tilburg, The Netherlands), both were 
administered intraperitoneally. Acute ischemia was induced by euthanizing the anaesthetized 
animal. Blood oxygenation in the mouse tongue was measured using differential path-length 
spectroscopy [21]. Blood oxygenation levels of ~50% were found in the anaesthetized mouse; 
this value dropped to 0% immediately (< 1 min) after administration of the euthanasia 
solution. All experiments were limited to four hours after anesthesia administration. 
2.2. Nonlinear spectral imaging microscope 
The basic NSIM setup used for detecting autofluorescence signal from in vivo keratinocytes 
was similar to that described previously [14]. A diagram of the experimental setup is shown in 
Fig. 1. The excitation light source (765 nm) was a mode-locked titanium:sapphire (Ti:Sa) 
laser (Tsunami, Spectra-Physics, Sunnyvale, CA), pumped by a 5W neodymium yttrium 
vanadate (Nd:YVO4) laser (Millennia, Spectra-Physics, Sunnyvale, CA). The laser light was 
scanned using a galvanometer mirror scanner (040EF, LSK, Stallikon, Switzerland). In 
addition to the beam-scanning mechanism, the microscope was also equipped with an XYZ 
piezo translation (sample) stage (Physik Instrumente, Karlsruhe/Palmbach, Germany). The 
laser light was focused by an objective lens on the sample and the fluorescence emission was 
collected by the same objective lens. The results reported here were acquired in the inverted 
geometry using an infinity-corrected oil-immersion objective lens (60× and NA = 1.40, 
Nikon, Japan). 
The emission passed through a dichroic mirror and was filtered by a set of short-pass 
Schott® optical glass filters (total thickness = 7 mm; BG-40, Schott, Mainz, Germany). The 
filtered light was dispersed by two prisms and focused on the charge-coupled device (CCD) 
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Halle Nachfl., Berlin, Germany). The spectrograph was equipped with a thermoelectrically 
cooled, back-illuminated CCD camera (Princeton Instruments, Spec-10:2KBUV, 16-bit, ST-
133 controller, typical read noise 3 e
- rms at 100-kHz digitization). In our experiments, the 
exposure time was limited to 2.1 ms per pixel and employed excitation powers of less than 5 
mW. Photobleaching was observed to be minimal at this low power level. Based on the 
recorded images prior to the administration of euthanasia solution, we estimated a 
fluorescence (bleaching) decay rate (1/e) of 2.5 × 10
3/frame at 2 min/frame. Data processing 
and visualization were carried out using a program (SpecView) written in IDL 6.0 (Research 
Systems Inc., Boulder, CO). 
 
Fig. 1. Schematic diagram of the spectral imaging setup. The intrinsic emission of a sample is 
epi-detected without a pinhole. The signal is spectrally dispersed by two prisms, focused with 
an achromat, and detected with a back-illuminated CCD array. 
Wavelength and instrument spectral response calibration of the instrument was carried out 
to ensure accurate spectral measurements. A white light source and a calibrated 
monochromator were used to calibrate the instrument wavelength and the calibration accuracy 
was better than 0.5 nm over the whole wavelength range. The spectral response correction 
was calculated by measuring the spectra of two standard fluorophores: tryptophan in water 
and quinine sulfate in perchloric acid [22]. 
2.3. Visualization and analysis of spectral image data 
The recorded spectral image data were converted to RGB images for visualization using a 
program written in IDL 6.0 (Research Systems Inc., Boulder, CO) as described in detail 
previously [4]. Briefly, the conversion procedure involves down sampling the 100-channel 
(wavelength) spectral image to a 3-channel (RGB) color image. The full spectral image data 
set were analyzed using a separate program written in IDL 6.0. Pixel-averaged spectra of 
selected regions-of-interest (ROIs) were obtained for spectral analysis depicted in Fig. 2 
(yellow dashed box). The basis of selecting an area as an alternative to using the whole image 
is to ensure that only keratinocytes from a single tissue layer, in our case mainly the stratum 
basale were analyzed. 
Linear spectral unmixing analysis was performed by means of iterative linear least squares 
fitting procedure (Gaussian multi-peaks, Origin® 6.1, OriginLab Corporation, Northampton, 
MA, USA). Three Gaussian curves were fitted globally using the difference spectra (see Fig. 3 
D) from all time points relative to the time before acute ischemia was induced, thus removing 
static components from the analyses. The shared parameters for this procedure were the 
spectral peak positions and spectral widths while the amplitudes were allowed to vary. All 
fitting procedures were carried out in the wavenumber space. The global fit yielded the time-
varying amplitudes of the spectral components attributed to the autofluorescence of protein-
bound and free NADH and flavins as depicted in Fig. 4 A. 
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3.1. Cellular autofluorescence modification following total acute ischemia 
The capability of nonlinear microscopy to produce optical sections through thick tissues 
allowed us to record spectral images of living cells inside the epidermis. In addition, the high 
sensitivity of the spectral imaging system across a broad spectral range (350 nm to 600 nm) 
permitted acquisition of autofluorescence spectral images with relatively high signal-to-noise 
ratio (SNR) using low excitation power levels, typically around 5 mW [14]. Long-term in vivo 
imaging of cells within tissues using the present setup is thus achieved with minimal 
photobleaching and low phototoxicity. 
 
Fig. 2. Representative time-lapse RGB spectral images of mouse keratinocytes in vivo before (t 
< 0 min) and during (t > 0 min) ischemia showing increase and decrease in autofluorescence 
(AF). Red arrows: hair follicles. Colors represent emission wavelength as indicated in color 
bar. All images are 224 × 224 pixels, 100 µm × 100 µm. 
Time series of spectrally-resolved nonlinear-excited fluorescence optical sections were 
recorded from the skin epidermis of anaesthetized living hairless mouse (see Fig. 2). Because 
of the undulating characteristic of epidermal layers, the recorded spectral image sections 
consisted of keratinocytes associated to stratum basale and stratum spinosum. Note that only 
keratinocytes in the stratum basale were analyzed. We acquired images of basal cells since 
their keratin content is less than that of the other epidermal layers, thus minimizing keratin 
autofluorescence contribution to the overall emission spectrum. Bright green-fluorescing hair 
follicles were also observed in the spectral images (see Fig. 2, red arrows). The mice were 
subjected to total acute ischemia during which the intrinsic fluorescence of the keratinocytes 
increased in intensity by an average of 71 ± 5% (averaged from t = 50 min to t = 80 min) as 
depicted in Fig. 3, A and B. At t > 80 min, a decrease in autofluorescence intensity was 
observed to below pre-ischemic baseline or normoxic levels. The autofluorescence of the hair 
follicles remained fairly constant ( ± 4%) throughout the experiment. The variation in the 
cellular autofluorescence emission spectral shape after the onset of ischemia is depicted in 
Fig. 3, A and C. The spectra showed an initial blue-shift of the spectral peak from 456 nm (t = 
0 min) to 450 nm (t = 20 min) and a subsequent red-shift to 455 nm (t = 80 min). At t = 150 
min, the autofluorescence spectral peak was observed to be 460 nm, 5 nm longer than the 
normoxic (t = 0 min) autofluorescence spectrum. The variation in the spectral shape as 
demonstrated by the shifting of the spectral peaks strongly indicates metabolic response to 
ischemia of at least two spectral components. The difference spectra, that is the difference 
between the autofluorescence spectrum at any given time point (ischemic) and the baseline 
(normoxic) autofluorescence spectrum at t = 0 min, showed a more clear evidence that at least 
two components with different response to ischemia comprise the cellular autofluorescence 
spectrum (see Fig. 3 D). Here, it can be deduced that during the early condition after the onset 
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long-wavelength spectral component. At ~80 min, both components have higher intensities 
relative to normoxic levels but of relatively equivalent ratio as that of the normoxic condition. 
At longer times, both components decreased in intensity below the normoxic level as depicted 
by negative values in the difference spectrum for t > 110 min (see Fig. 3 D). 
 
Fig. 3. A: Color map of the temporal behavior of the autofluorescence spectra obtained from 
the pixel-averaged spectral data from a region of interest (ROI; yellow box in Fig. 2). White 
line indicates the average peak wavelength (λ = 456 nm) of the autofluorescence spectra before 
ischemia. Black dotted line indicates the autofluorescence peak wavelength depicting spectral 
blue-shift after ischemia (t > 0 min) and a red-shift at t > 50 min. B: Normalized integrated 
autofluorescence intensity (integrated between 400 nm and 600 nm). C: ROI pixel-averaged 
autofluorescence spectra at representative time points showing spectral variation during 
ischemia. D: Difference spectra (relative to AF spectrum at t = 0 min) at representative time 
points. 
3.2. Probing bound/free NADH in mouse keratinocytes 
To observe the dynamics of cellular components related to metabolic cycle following 
ischemia, linear spectral unmixing of the pixel-averaged spectra was carried out. Globally 
fitting the difference spectra at all time points after the onset of ischemia (t > 0 min) in 
wavenumber space with model Gaussian curves yielded three spectral components with peak/ 
full-width-at-half-maximum (FWHM) values of: 448 nm/ 91 nm; 459 nm/ 91 nm and; 528 
nm/ 77 nm (see Fig. 4 A). Shown in Fig. 4 B, is an example of the fitting of the three 
components depicting a good fit of the sum of the fit to the data with typical fitting r
2 
coefficient of determination of >0.99. Note also that the third spectrum has a minimal 
contribution to the overall spectrum. To validate the results of the global fitting procedure (i.e. 
peak wavelength of the spectral components), we plotted the χ
2 (global fitting) error as a 
function of the peak wavelengths of the components 1 and 2 as illustrated in Fig. 4, C–E. 
Here, the local minimum corresponds to peak wavelength values of 448 nm and 459 nm. 
These peak wavelengths as well as the spectral widths are in good agreement with literature 
values for protein-bound and free NADH [23,24]. 
The time-dependence of the amplitudes of the three spectral components for two 
independent in vivo experiment sets are shown in Fig. 5, A and B. Spectral unmixing revealed 
that indeed the third spectral component with amplitude A3, attributed to flavin   
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Fig. 4. A: Three spectral components used for spectral unmixing with peak/ full-width-at-half-
maximum (FWHM) values of: (1) 448 nm/ 91 nm; (2) 459 nm/ 91 nm; and (3) 528 nm /77 nm, 
attributed to protein-bound and free NADH and flavins, respectively. Curves are normalized to 
the peaks’ amplitude. B: Spectral unmixing analysis showing the spectral components (1 to 3) 
attributed to: (1) protein-bound NADH; (2) free NADH; and (3) flavins, and the sum of the 
fitted components. Also shown is the residual of the fit. Fitting r
2 coefficient of determination 
is 0.996. C: Color map of the χ
2 error obtained by global fitting ten arbitrary difference spectra 
as a function of the peak wavelengths of the first two components. The intersection point of the 
two dotted lines indicates the local minimum (λ1 = 448 nm, λ2 = 459 nm). D and E: 
Dependence of the global fitting error to the peak wavelength of spectral component 1 (at λ2 = 
459 nm) and peak wavelength of spectral component 2 (at λ1 = 448 nm), respectively. 
 
Fig. 5. A and B: Time-dependence of the relative amplitudes relative to the average component 
amplitudes at t < 0 min (normoxic) of each of the fitted components from two independent in 
vivo experiment sets. A minimum of 25 epidermal cells (within the region of interest as 
depicted in Fig. 2, yellow box), was measured for each time point, for each experiment. 
Reference (normoxic) condition (t  0 min), ischemia (t > 0 min). 
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experiments showed a significant difference between the amplitude variation of the two 
spectral components A1 and A2, attributed to protein-bound and free NADH fluorescence, 
respectively. Furthermore, similarities were found between the amplitude variations of 
corresponding spectral components. For instance, in both experiments, A2 showed a broad 
peak in time (FWHM, ~100 min) with maxima at ~100 min while A1 demonstrated a 
relatively narrower peak in time (FWHM, ~50 min) with maxima at ~50 min. These suggest 
that at early times following ischemia onset, the increase in fluorescence is mainly due to 
increase in protein-bound NADH (113%) and after t = 50 min, the protein-bound NADH 
autofluorescence decreases below normoxic levels (~70%) while free NADH remained 
increasing (up to ~85%). After ~100 min, free NADH gradually decreases below normoxic 
levels (~20%). 
 
Fig. 6. Left axis: Shown are the amplitudes of the spectral components A1 and A2 attributed to 
protein-bound and free NADH, respectively, normalized to the average pre-ischemic values. 
Right axis: Relative ratio between the amplitudes of the two spectral components A2 and A1, 
attributed to free and protein-bound NADH, respectively. 
The relative amplitudes (relative to the average component amplitudes at t<0) and the 
relative ratio of the two spectral components attributed to protein-bound and free NADH are 
shown in Fig. 6. Here, the results show that at early times after the onset of ischemia, the 
contributions of both protein-bound and free NADH increases but with higher increase in the 
contribution of the protein-bound. The increase in NADH autofluorescence following 
ischemia onset is an indication of the shift in the cellular redox state to a more reduced state. 
Ischemia results in complete glucose and oxygen deprivation (hypoxia followed by anoxia) 
and the absence of oxygen is known to inhibit oxidative phosphorylation. It has been shown 
that inhibition of oxidative phosphorylation (in this specific case by a mitochondrial complex 
1 inhibitor) is accompanied by a significant increase in cellular protein-bound NADH 
fluorescence [8]. This might be related to the results of a study showing that binding of 
NADH to complex I enhances the fluorescence by 10-fold compared to only a 1.5 to 2-fold 
enhancement when they are bound to other sites including alcohol dehydrogenase, aldehyde 
dehydrogenase, glutamate dehydrogenase, malate dehydrogenase, lactate dehydrogenase, 
succinate dehydrogenase and citrate synthase [25]. Hypoxia results in the accumulation of 
NADH in complex I leading to a strong increase in the protein-bound NADH fluorescence, as 
observed here. This result is in agreement with the previous results on isolated hepatocytes in 
which a maximum value of the ratio bound:free NADH was observed at ~70 min after 
#143305 - $15.00 USD Received 25 Feb 2011; revised 19 Mar 2011; accepted 29 Mar 2011; published 1 Apr 2011
(C) 2011 OSA 1 May 2011 / Vol. 2,  No. 5 / BIOMEDICAL OPTICS EXPRESS  1037exposure to hypoxia . After ~50 min, a sharp decrease in protein-bound NADH contribution 
was observed while the free NADH contribution remained increasing. A reasonable 
explanation is anoxia-mediated mitochondrial damage and subsequent autophagy [9]. This 
inhibition of mitochondrial ATP production results in the increased production of ATP by 
glycolysis and lactate fermentation (anaerobic metabolism). This shift in metabolic pathway 
results in a redistribution of protein-bound NADH to enzyme binding sites with shorter 
lifetimes (lower fluorescence quantum yield) [7,13], such as lactate dehydrogenase. Increased 
glycolysis is also observed in (pre)tumor cells (Warburg effect) and it has been reported that 
in such cells, increased levels of free NADH fluorescence are observed [6]. The duration in 
which the cell relies on glycolysis for ATP production depends on the amount of glucose in 
the tissue and the glucose uptake rate. The slow decrease in NADH autofluorescence after 
~100 min is therefore most likely due to glucose deprivation [26]. 
4. Discussion 
The results presented in this work demonstrate the dynamic effect of total acute ischemia on 
the autofluorescence spectra of in vivo mouse skin keratinocytes. Linear spectral unmixing 
analysis suggests that the metabolically active fluorophores are protein-bound and free 
NADH. The contributions of protein-bound and free NADH show different dynamic reactions 
to hypoxia, anoxia and ischemia. NADH protein-bound to the complex I (NADH:ubiquinone 
oxidoreductase) of mitochondria is the major source of protein-bound NADH fluorescence. 
The temporal protein-bound NADH profile shows the dynamics of the transition of normoxia 
to hypoxia to anoxia. The ratio between protein-bound and free NADH change when the cells 
shift to anaerobic metabolism and finally the deprivation of glucose reduces the total NADH 
fluorescence. Our results, therefore, signify that in mouse keratinocytes all the major 
metabolic pathways (glycolysis, anaerobic fermentation and oxidative phosphorylation) 
respond to the loss of blood-supplied (via capillaries) oxygen and glucose. Another important 
implication of our results is the confirmation of the presence of metabolically functional 
mitochondria in epidermal keratinocytes, contrary to the conclusion of a recent study that 
keratinocytes are functionally anaerobic and that keratinocytic mitochondria are metabolically 
dysfunctional [27]. Our observation showing significant response of mitochondrial-bound 
NADH to ischemia strongly suggests inhibition of mitochondrial complex I, hence, an 
evidence of mitochondrial oxidative phosphorylation of keratinocytes under normoxic 
conditions. 
The results also demonstrate that although there is evidence supporting the hypothesis that 
cutaneous uptake of atmospheric oxygen contributes significantly to the oxygen supply of 
epidermis [28], capillary oxygen supply remains to be the major source for epidermal 
metabolic function. Based on optical measurements of oxygen flux on the surface of human 
skin, measured values of oxygen diffusion in skin tissues, and assumption of homogeneity of 
skin, the thickness of the skin tissue that is supplied by atmospheric oxygen was estimated to 
be 266–375 μm [28]. The measurements presented in the present study were carried out at 
depths of ~50 μm relative to the surface of the skin and the analysis of the results clearly 
showed metabolic response to complete deprivation of blood-supplied oxygen. On the other 
hand, the possibility that obstruction of blood supply establishes a hypoxic rather than an 
anoxic environment cannot be disregarded. In fact, it may even explain the slow metabolic 
response (~2 h) of the keratinocytes following the loss of blood-supplied oxygen. 
The interpretation of the results of this study relies significantly on the validity of the 
spectral unmixing procedure which included fitting of the spectra with mathematically-
modeled Gaussians as reference spectra. Although the Gaussian components do not exactly 
represent the spectra of pure compounds, the results strongly suggest that these fitted 
components are convenient representations of protein-bound and free NADH. On the other 
hand, the use of spectra of pure compounds as reference spectra in spectral unmixing will not 
yield more accurate results since the measured emission spectra are modulated by tissue inner 
filter effects (i.e., light scattering and absorption in turbid media), tissue viscosity, refractive 
index and solvent effects [5,24,29]. Furthermore, the experiments were necessarily carried out 
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normoxic condition could influence the dynamic metabolic response of epidermal 
keratinocytes. A recent report showed a small change (<9%) in skin oxygenation of mice after 
one hour of administration of ketamine anesthesia under normoxic conditions [30]. 
Most imaging experiments on free and protein-bound NADH were carried out using two-
photon excited fluorescence lifetime imaging (FLIM) [8–13]. Discrimination between the free 
and protein-bound NADH is achieved by taking advantage of the difference in their 
fluorescence lifetimes: the short lifetime component is attributed to the free NADH (τfreeNADH 
= 0.3 to 0.5 ns) while the long lifetime component is attributed to the protein-bound NADH 
(τboundNADH = 1.6 to 3.7 ns) [8,9,12]. Comparison between FLIM and spectral imaging in terms 
of ability to discriminate between protein-bound and free NADH is not straightforward and 
depending on the type of experiment different aspects need to be taken into account. An 
important factor in the in-vivo imaging of NADH is the sensitivity and non-invasiveness of 
the applied method: autofluorescence levels are in general low and in in-vivo experiments 
only low excitation levels are tolerated. The high time resolution of FLIM dictates the use of 
photomultiplier tubes or avalanche photo diodes with peak quantum efficiencies in the range 
of 10-40% while the present spectral imaging setup is equipped with a detector with a >90% 
peak quantum efficiency. Moreover, FLIM requires the use of band-pass filters to select the 
emission of the NADH and suppress autofluorescence contributions from other components 
such as flavins. In contrast, spectral imaging detects a broad spectral range covering the entire 
(protein-bound and free) NADH emission band. In our experience both techniques require 
comparable amounts of signal for reliable analyses of the protein-bound and free NADH 
components. The higher sensitivity of spectral imaging results in discrimination between the 
two components at relatively short pixel dwell times of 2 ms per pixel compared to 11 to 17 
ms per pixel [9–12] in FLIM studies. Furthermore, the spectral imaging provides valuable 
additional information on morphology and the presence of other components besides NADH. 
Finally, this study has demonstrated the capability of nonlinear spectral metabolic imaging 
in obtaining both morphological and biochemical information to unravel the dynamic 
metabolic response of living cells inside tissues for a long period of time following acute 
ischemia. Our results represent clear indication that spectral imaging effectively discriminates 
protein-bound and free NADH. 
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